Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia

In this retrospective study, we evaluated the impact of pre- and posttransplant minimal residual disease (MRD) detected by multiparametric flow cytometry (MFC) on outcome in 160 patients with ALL who underwent myeloablative allogeneic hematopoietic cell transplantation (HCT). MRD was defined as dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Merav, Wood, Brent L., Radich, Jerald P., Doney, Kristine C., Woolfrey, Ann E., Delaney, Colleen, Appelbaum, Frederick R., Gooley, Ted A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981457/
https://www.ncbi.nlm.nih.gov/pubmed/24778882
http://dx.doi.org/10.1155/2014/421723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981457/
https://www.ncbi.nlm.nih.gov/pubmed/24778882
http://dx.doi.org/10.1155/2014/421723

Ejemplares similares